Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ayman. B. Farag"'
Publikováno v:
Pharmaceutical Chemistry Journal. 56:777-784
Autor:
M. H. Sanad, Fawzy A. Marzook, Ayman B. Farag, Sudip Kumar Mandal, Syed F. A. Rizvi, Jeetendra Kumar Gupta
Publikováno v:
Radiochimica Acta. 110:267-277
This study focuses on the synthesis and preliminary bio-evaluation of [99mTc]-technetium tricarbonyl procainamide ([99mTc]-technetium tricarbony PA) as a viable cardiac imaging agent. The compound, [99mTc]-technetium tricarbony PA, was synthesized by
Publikováno v:
Radiochimica Acta. 110:67-74
This work focuses on tracking peptic ulcer localized in mice. The formation of a [99mTc]dithiocarbamate of famotidine complex at optimum conditions of reaction temperature (37 °C), reaction time (30 min), pH of the reaction mixture (5), amount of su
Autor:
M. H. Sanad, Sudip Kumar Mandal, Francis Verpoort, Syed Rizvi, Soumya Stuti Patnaik, A. S. M. Fouzy, Ayman B. Farag, Sabry A. Bassem, F. A. Marzook, Hanan M. Eyssa
Publikováno v:
Radiochemistry. 63:642-650
Two 99mTc cores, 99mTc tricarbonyl and 99mTc-Sn(II), are compared in labeling of Lansoprazole (Lans). The optimum conditions of Lansoprazole labeling with 99mTc in the presence of SnCl2·2H2O as a reducing agent are as follows: pH 8, 100 μg of SnCl2
Autor:
M. H. Sanad, Sudip Kumar Mandal, F. A. Marzook, Hanan M. Eyssa, Sabry A. Bassem, Ayman B. Farag, Syed Rizvi, Soumya Stuti Patnaik, A. S. M. Fouzy, Francis Verpoort
Publikováno v:
Radiochemistry. 63:635-641
99mTc nitrido-Levetiracetam was prepared using the 99mTc nitrido core for labeling. The reaction conditions were optimized to get the highest radiochemical purity (98%): substrate amount 2 mg, Sn(II) (reducing agent) amount 50 µg, pH 7, 30 min, ambi
Autor:
Mahmoud S. Ahmed, Ayman B. Farag, Ian N. Boys, Ping Wang, Ivan Menendez-Montes, Ngoc Uyen Nhi Nguyen, Jennifer L. Eitson, Maikke B. Ohlson, Wenchun Fan, Matthew B. McDougal, Katrina Mar, Suwannee Thet, Francisco Ortiz, Soo Young Kim, Ashley Solmonson, Noelle S. Williams, Andrew Lemoff, Ralph J. DeBerardinis, John W. Schoggins, Hesham A. Sadek
Publikováno v:
Biomedicine & Pharmacotherapy. 162:114614
Publikováno v:
Chemical Biology & Drug Design. 98:751-761
This study demonstrated the tracking of ulcerative colitis, which is considered a stressful immune disease. Although there are many ways to test for this disease including dependence on gases, dyes, and painful anal endoscopy, these treatment modalit
Publikováno v:
Radiochemistry. 63:520-525
Azilsartan (AZ) was labeled with 131I using Chloramine-T as oxidizing agent. Factors affecting the labeling efficiency were systematically studied, and optimum conditions were found: oxidizing agent amount 100 μg, substrate amount 100 μg, pH 6, rea
Publikováno v:
Radiochimica Acta. 109:575-582
This study presents development and characterization of a radiotracer, [125I]iodonefiracetam ([125I]iodoNEF). Labeling with high yield and radiochemical purity was achieved through the formation of a [125I]iodoNEF radiotracer after investigating many
Publikováno v:
Radiochimica Acta. 109:477-483
In this work, the radiotracer [99mTc]nitrido-oxiracetam complex was labeled in the presence of 99mTc-nitrido as a core. In order to get the highest radiochemical purity, many effective factors have been studied such as temperature of the reaction, ti